Canadian company seeks to stand out with domestically-made generic Ozempic - CBC

AI Briefing

• – Canadian company Aspen Pharmacare plans to offer a domestically-made generic version of the diabetes medication Ozempic by Q3 2026.
• – The company's move aims to compete with existing generic versions of the drug, which are currently made overseas.
• – Aspen Pharmacare's plan is expected to provide Canadians with more affordable access to the medication.